How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca<sup>2+</sup>
We examined the kinetics and mechanisms by which monoclonal antibodies (mAbs) utilize complement to rapidly kill targeted cancer cells. Based on results from flow cytometry, confocal microscopy and high-resolution digital imaging experiments, the general patterns which have emerged reveal cytotoxic...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2020-09-01
|
| Serie: | Antibodies |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2073-4468/9/3/45 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|